Novartis Highlights Strong R&D Pipeline, Plans For Multiple New ...
Medical News Today (press release), UK - Nov 29, 2006... AGO178 (agomelatine), seeking to become a new once-daily treatment for patients with major depression, is set to begin Phase III trials in the US by the end of ...
Source: www.medicalnewstoday.com
The Search for New Off-Label Indications for Antidepressant ...
Focus (subscription) - Dec 6, 2006... 11, 1981, we initiated the first proof-of-concept study of the new SSRI, fluoxetine, in the treatment of major depression (11) Fifty-one patients were randomly ...
Source: focus.psychiatryonline.org
Click here for more information about depression test depression test
<< Home